In summary, we identified LIF as a tumor promoter in HCC and systematically investigated its oncogenic role in facilitating cancer cell growth and metastasis by modulating mitophagy through a new signaling pathway of LIF/p38MAPK/p62. This evidence concerns the gene LIF and hepatocellular carcinoma.